Thursday, 26 March 2015

Scientists trace genomic evolution of high-risk leukemia

By genomic sequencing of leukemia cells from relapsed patients at different stages, scientists have discovered key details of how acute lymphoblastic leukemia (ALL) cells mutate to survive chemotherapy. These mutations enable the cells to proliferate, causing relapse and often death. The researchers said their findings will lead to new tests to monitor children in remission and to detect signs of relapse. Read more here.

No comments:

Post a Comment